Skip to content

C.E.R. - CLINICAL ENGINEERING & RESEARCH

Active Risk: not assessed
Private limited companyfounded 1983active for 42 yearsBogaertstraat 24, 9830 Sint-Martens-Latem, BelgiumKBO/BCE: BE 0425.363.905
Summary

C.E.R. - CLINICAL ENGINEERING & RESEARCH is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €13.3m and a net result of €197,395. Its solvency ranks better than 74% of 6,655 sector peers (NACE 64, financial year 2025). The company has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
C.E.R. - CLINICAL ENGINEERING & RESEARCHActive
Risk analysis ReportCompare

Overview

Activity
Activities of holding companies
NACE 64210
4th oldest company in Sint-Martens-Latem, Finance and insurance sector1 site
Size
€17.1mtotal assets 2025
Staff
2 FTE
Equity
€13.3m
Profit
€197,395
Turnover not published (abbreviated format)
Financial health
Financial institution: outside the modelBankruptcy probability: sector outside the model
Structure
Holdings
1
2025 accounts 35 days early1 of 5 deeds summarised
SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model
Model not applicable to financial institutions
The Checked score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Bankruptcy probability, 12 months

This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
35 days early
2024
23 days early
2013
2 days early
2012
1 day early
2011
29 days late
2010
19 days late
2009
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days after the deadline; the sector median (NACE 64) for financial year 2024 is 14 days before the deadline, and 28% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 July (4 of the last 5 filed years within 32 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Resignations: RUYSSCHAERT Jan (manager) and VANHOUTEGHEM…Appointments: RUYSSCHAERT Jan (director) and…

Key points

  • Positive: Among the best 5% on equitysector median €582,236 · 6,656 companies €13.3m View
  • Positive: Filed on time since financial year 2012accounts within the deadline every year 4 years View
  • Active since 1983founded 20-12-1983 42 years View

By topic

Financials

Financial year
2025
Total assets
€17.1m
Profit
€197,395
Solvency
77.9%
Total assets▼ 2.5%
Net result
20242025
Go to Financials

Network & group

Subsidiaries, all levels
2
Direct holdings
1
Connected companies
1

2 subsidiaries

Go to Network & group

Timeline

Events
33
Since
1985
Next accounts
by 31-07-2027
  1. 29-07-2014Annual accounts filed
  2. 30-07-2013Annual accounts filed
  3. 29-08-2012Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Activities of holding companiesNACE 64210
Founded
20-12-1983
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about C.E.R. - CLINICAL ENGINEERING & RESEARCH

What is the company number of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
0425.363.905. In Belgium the VAT number is the company number with BE in front: BE 0425.363.905.
Where is C.E.R. - CLINICAL ENGINEERING & RESEARCH based?
The registered office is at Bogaertstraat 24, 9830 Sint-Martens-Latem.Company details
What does C.E.R. - CLINICAL ENGINEERING & RESEARCH do?
According to the KBO register, the main activity is activities of holding companies (NACE 64210).
What is the legal form of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
Private limited company (BV).
When was C.E.R. - CLINICAL ENGINEERING & RESEARCH founded?
On 20-12-1983.
Is C.E.R. - CLINICAL ENGINEERING & RESEARCH still active?
Yes, C.E.R. - CLINICAL ENGINEERING & RESEARCH is an active enterprise in the KBO register.
How many employees does C.E.R. - CLINICAL ENGINEERING & RESEARCH have?
On average 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is C.E.R. - CLINICAL ENGINEERING & RESEARCH profitable?
In financial year 2025, C.E.R. - CLINICAL ENGINEERING & RESEARCH made a profit of €197,395.
Where can I find the annual accounts of C.E.R. - CLINICAL ENGINEERING & RESEARCH?
C.E.R. - CLINICAL ENGINEERING & RESEARCH filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of C.E.R. - CLINICAL ENGINEERING & RESEARCH due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to C.E.R. - CLINICAL ENGINEERING & RESEARCH

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What changed in the latest annual accounts?What changed Is the workforce growing, and do people stay?Employer check

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure